Mozobil

(plerixafor)

1.2 ML plerixafor 20 MG/ML Injection [Mozobil]

NO BOXED WARNING

Dosage & administration

* Initiate Mozobil treatment after the patient has received G-CSF once daily for 4 days.
* Repeat Mozobil dose up to 4 consecutive days.
* Dose based on patient weight
* Less than or equal to 83 kg: 20 mg dose or select dose based on 0.24 mg/kg actual body weight.
* greater than 83 kg: select dose based on 0.24 mg/kg actual body weight.

* Administer by subcutaneous injection approximately 11 hours prior to initiation of apheresis.
* Renal impairment: If creatinine clearance is ≤50 mL/min, decrease dose by one-third to 0.16 mg/kg.

biomarker testing

Mozobil clinical details

Genetic testing requirements were obtained from the NCCN guidelines for each cancer type.

drug label

Mozobil prescribing information

Contact Medical Science Liaison Report Adverse Event

prior authorization

Mozobil prior authorization resources

Most recent Mozobil prior authorization forms

View By Payer

Verified: Nov 27, 2023Cigna - Mozobil Prior Authorization Form

Complete Letter of Medical Necessity

Coverage Authorization Appeal

Learn More

Benefits investigation

Sanofi Patient Connection Application - English

Sanofi Patient Connection Application - Spanish

Learn More

Reimbursement help (FRM)

Reimbusement Information

Learn More

financial assistance

Mozobil financial assistance options

Foundation programs

under insured

no insurance

goverment insurance

65+

Sanofi Patient Connection Application - English

Sanofi Patient Connection Application - Spanish

Learn More

Overview

Charitable 501(c)(3) organizations provide direct cost-sharing and other support (e.g., travel, counseling) through disease-state funds to indigent patients on first-come first-served basis
These organizations may receive financial contributions from drug manaufacturers for particular disease-state funds that cannot provide funds directly to patients - the foundation must be independent/unaligned

Patient benefit

Patients apply for grants that cover a portion (or all) of their out-of-pocket costs (deductibles and co-pays) until the grant is exhausted

Patient eligibility

Patients must apply and meet eligibility criteria including income level (typically a multiple of federal poverty line), specific diagnosis, insurance status, etc.

How to sign up

Patients submit proof of out-of-pocket drug costs to charities for reimbursement

patient education

Mozobil patient education

To share resource; ask patient to:

1.Pull out phone

2.Open camera

3.Scan QR code with camera

4.Tap link

Patient toolkit

About Mozobil

ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Learn More

Mozobil FAQs

How is the dosage of Mozobil?Mozobil is available in 1 dosages, including 20 mg/ml Injection 1.2 ml

What does Mozobil treat?Mozobil treats Non-Hodgkin Lymphoma and Multiple Myeloma

What is Mozobil made of?Mozobil contains plerixafor which is a Hematopoietic Stem Cell Mobilizer

How Is Mozobil Administered?Mozobil is administered as a Injectable

FAQ Data Source

Mozobil

Dosage & administration

biomarker testing

Mozobil clinical details

drug label

Mozobil prescribing information

prior authorization

Mozobil prior authorization resources

Most recent Mozobil prior authorization forms

Benefits investigation

Reimbursement help (FRM)

financial assistance

Mozobil financial assistance options

Foundation programs

patient education

Mozobil patient education

Patient toolkit

people also ask

Mozobil FAQs